MedTrace Logo

A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care

NCT02807857 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1415

Last updated 2021-02-24

Study results available
· View outcomes & findings →

Summary

This low interventional study, whose unique intervention was to measure the blood level of a biomarker called NT-proBNP in chronic heart failure patients daily followed-up by Primary Care Physicians (PCPs) in Europe, assessed if the cardiologist referral guided by NT-proBNP measurement in patients who were currently judged by PCPs as being stable, would lead to optimization of HF treatment, defined in adherence to treatment recommendations of the current European Society of Cardiology guidelines for the treatment of heart failure.

Conditions

  • Chronic Heart Failure (CHF)

Interventions

PROCEDURE

Standard care

Patients will receive the treatment that their primary care physician has decided to prescribe for their disease

Sponsors & Collaborators

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-07
Primary Completion
2018-03-23
Completion
2018-03-23

Countries

  • Belgium
  • Croatia
  • Cyprus
  • Denmark
  • Estonia
  • France
  • Hungary
  • Israel
  • Italy
  • Latvia
  • Lithuania
  • Malta
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovenia
  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02807857 on ClinicalTrials.gov